Summary

The Global Probiotic Ingredients Market is valued approximately at USD 0.42 billion in 2024 and is anticipated to grow at a robust CAGR of 8.50% over the forecast period 2025–2035. Probiotic ingredients, derived from specific strains of bacteria or yeast, have emerged as a cornerstone of functional nutrition and therapeutic innovation. These microorganisms are introduced intentionally into food systems and pharmaceutical products to restore gut health, enhance immunity, and deliver preventive healthcare. Rising consumer inclination towards digestive wellness, immunity-boosting foods, and personalized nutrition solutions has dramatically elevated the market potential. In parallel, product innovations targeting novel delivery mechanisms such as microencapsulation and synbiotics have carved competitive differentiation for key stakeholders across global markets.
The growing integration of probiotics into functional food and beverage portfolios—especially dairy products, fermented drinks, and supplements—has unlocked remarkable commercial opportunities. Brands have been capitalizing on clean-label trends and health-conscious consumer behavior by introducing probiotics in everyday consumables. Moreover, rising clinical interest in the gut-brain axis and microbiome modulation has stimulated investments in probiotic therapeutics for applications ranging from mental health to dermatology. On the animal nutrition front, probiotics are increasingly replacing antibiotics in livestock feed, enhancing digestive efficiency and immunity in poultry and cattle—particularly relevant in post-antibiotic regulatory landscapes across the EU and North America. Meanwhile, the pharmaceutical industry's increasing exploration of probiotic APIs for conditions such as IBS, urogenital disorders, and antibiotic-associated diarrhea continues to expand the functional scope of this bioactive category.
From a regional standpoint, North America currently commands a prominent share of the global probiotic ingredients market, underpinned by heightened consumer awareness, advanced healthcare infrastructure, and widespread demand for fortified consumables. The U.S., in particular, has witnessed a proliferation of probiotic-infused products and dietary supplements targeted toward adults, children, and aging populations alike. Meanwhile, Asia Pacific is poised to emerge as the fastest-growing region, with China, India, and Japan spearheading growth due to increasing disposable income, a rapidly expanding middle class, and a growing appetite for functional food innovations. Europe, with its rich history of fermented food culture and stringent regulatory oversight from EFSA, remains a mature yet innovation-driven market, with Scandinavian countries setting benchmarks in probiotic R&D.
Major market player included in this report are:
• DuPont de Nemours, Inc.
• Kerry Group plc
• Chr. Hansen Holding A/S
• Lallemand Inc.
• Probi AB
• Archer Daniels Midland Company
• Koninklijke DSM N.V.
• Novozymes A/S
• Yakult Honsha Co., Ltd.
• BioGaia AB
• Danone S.A.
• Ganeden, Inc.
• Morinaga Milk Industry Co., Ltd.
• UAS Laboratories LLC
• Sabinsa Corporation
Global Probiotic Ingredients Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Application:
• Functional Foods & Beverages
• Pharmaceuticals
• Animal Nutrition
By Source:
• Bacteria
• Yeast
By Form:
• Dry
• Liquid
By End User:
• Human
• Animal
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Probiotic Ingredients Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
 1.2.1. Forecast Model
 1.2.2. Desk Research
 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
 1.4.1. Market Definition
 1.4.2. Market Segmentation
1.5. Research Assumption
 1.5.1. Inclusion & Exclusion
 1.5.2. Limitations
 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Probiotic Ingredients Market Forces Analysis
3.1. Market Forces Shaping the Global Probiotic Ingredients Market (2024–2035)
3.2. Drivers
 3.2.1. Rising consumer demand for gut health and immunity-boosting foods
 3.2.2. Growing use of probiotics in livestock nutrition to replace antibiotics
3.3. Restraints
 3.3.1. Regulatory complexities in different regional markets
 3.3.2. Stability challenges of probiotics during processing and shelf life
3.4. Opportunities
 3.4.1. Emergence of next-generation probiotic strains and delivery technologies
 3.4.2. Increasing adoption of probiotics in mental health and dermatology applications
Chapter 4. Global Probiotic Ingredients Industry Analysis
4.1. Porter’s 5 Forces Model
 4.1.1. Bargaining Power of Buyer
 4.1.2. Bargaining Power of Supplier
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
 4.3.1. Political
 4.3.2. Economical
 4.3.3. Social
 4.3.4. Technological
 4.3.5. Environmental
 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Probiotic Ingredients Market Size & Forecasts by Application 2025–2035
5.1. Market Overview
5.2. Functional Foods & Beverages
 5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.2.2. Market Size Analysis, by Region, 2025–2035
5.3. Pharmaceuticals
 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.3.2. Market Size Analysis, by Region, 2025–2035
5.4. Animal Nutrition
 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.4.2. Market Size Analysis, by Region, 2025–2035
Chapter 6. Global Probiotic Ingredients Market Size & Forecasts by Source 2025–2035
6.1. Market Overview
6.2. Bacteria
 6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.2.2. Market Size Analysis, by Region, 2025–2035
6.3. Yeast
 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.3.2. Market Size Analysis, by Region, 2025–2035
Chapter 7. Global Probiotic Ingredients Market Size & Forecasts by Form 2025–2035
7.1. Market Overview
7.2. Dry
 7.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 7.2.2. Market Size Analysis, by Region, 2025–2035
7.3. Liquid
 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 7.3.2. Market Size Analysis, by Region, 2025–2035
Chapter 8. Global Probiotic Ingredients Market Size & Forecasts by End User 2025–2035
8.1. Market Overview
8.2. Human
 8.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 8.2.2. Market Size Analysis, by Region, 2025–2035
8.3. Animal
 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 8.3.2. Market Size Analysis, by Region, 2025–2035
Chapter 9. Global Probiotic Ingredients Market Size & Forecasts by Region 2025–2035
9.1. Probiotic Ingredients Market, Regional Market Snapshot
9.2. Top Leading & Emerging Countries
9.3. North America Probiotic Ingredients Market
 9.3.1. U.S.
  9.3.1.1. Application Breakdown
  9.3.1.2. Source Breakdown
  9.3.1.3. Form Breakdown
  9.3.1.4. End User Breakdown
 9.3.2. Canada
  9.3.2.1. Application Breakdown
  9.3.2.2. Source Breakdown
  9.3.2.3. Form Breakdown
  9.3.2.4. End User Breakdown
9.4. Europe Probiotic Ingredients Market
 9.4.1. UK
 9.4.2. Germany
 9.4.3. France
 9.4.4. Spain
 9.4.5. Italy
 9.4.6. Rest of Europe
9.5. Asia Pacific Probiotic Ingredients Market
 9.5.1. China
 9.5.2. India
 9.5.3. Japan
 9.5.4. Australia
 9.5.5. South Korea
 9.5.6. Rest of Asia Pacific
9.6. Latin America Probiotic Ingredients Market
 9.6.1. Brazil
 9.6.2. Mexico
9.7. Middle East & Africa Probiotic Ingredients Market
 9.7.1. UAE
 9.7.2. Saudi Arabia
 9.7.3. South Africa
 9.7.4. Rest of Middle East & Africa
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. DuPont de Nemours, Inc.
 - Company Overview
 - Key Executives
 - Company Snapshot
 - Financial Performance (Subject to Data Availability)
 - Product/Services Port
 - Recent Development
 - Market Strategies
 - SWOT Analysis
10.3. Kerry Group plc
10.4. Chr. Hansen Holding A/S
10.5. Lallemand Inc.
10.6. Probi AB
10.7. Archer Daniels Midland Company
10.8. Koninklijke DSM N.V.
10.9. Novozymes A/S
10.10. Yakult Honsha Co., Ltd.
10.11. BioGaia AB
10.12. Danone S.A.
10.13. Ganeden, Inc.
10.14. Morinaga Milk Industry Co., Ltd.
10.15. UAS Laboratories LLC
10.16. Sabinsa Corporation